H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3...

Area of Science:

• Epigenetics
• Cancer Biology
• Genomics

Background:

• Diffuse Midline Glioma (DMG) is driven by the H3.3K27M mutation.
• This mutation inhibits the Polycomb Repressive Complex 2 (PRC2), reducing H3K27 trimethylation and altering the epigenome.

Purpose of the Study:

• To investigate the epigenetic effects of the H3.3K27M mutation in DMG.
• To differentiate the roles of PRC2 inhibition versus the K27M mutation itself in gliomagenesis.

Main Methods:

• Established isogenic DMG cell lines with CRISPR-Cas9 editing for H3.3 WT and H3.3K27M mutations.
• Performed RNA-seq and ATAC-seq analyses on edited cell lines, including PRC2 component (EZH1/2) deletions.

Main Results:

• H3.3K27M mutation causes epigenetic changes independent of PRC2 function.
• K27M mutation leads to balanced gene deregulation with a repressive effect on pathways.
• Genes uniquely altered by K27M showed increased chromatin accessibility and upregulation, essential for tumor formation in xenografts.

Conclusions:

• H3.3K27M mutation alters chromatin accessibility and gene expression independently of H3K27 methylation.
• The PRC2-independent function of K27M is critical for DMG development.
• Identified novel pathways and targets for therapeutic intervention in DMG.